All In Biotech

Drug Trial Radar · NCT04908683

A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older

A Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of an Ad26.RSV.preF-based Vaccine in the Prevention of Lower Respiratory Tract Disease Caused by RSV in Adults Aged 60 Years and Older

Last checked: Nov 19, 2026Latest source record: Nov 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 25,236 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

25,236

Actual

Start

Jul 21, 2021

Primary completion

Jul 21, 2023

Study completion Jul 21, 2023

Sponsor

Lead sponsor
Janssen Vaccines & Prevention B.V.Johnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jun 1, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study will enroll up to 27,200 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and above.

Conditions

  • Respiratory Syncytial Viruses
  • Lower Respiratory Tract Disease

Interventions

  • Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preFBiological

    Participants will receive a single IM injection of an RSV vaccine.

  • PlaceboBiological

    Participants will receive a single IM injection of matching placebo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With First Occurrence of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV) Mediated Lower Respiratory Tract Disease (LRTD)Time frame: From Baseline (Day 1) up to 12 months

Locations

272 sites in 14 countries. Site status is shown where the registry gives one.

  • Central Research Associates, Inc.

    Birmingham, Alabama

  • Synexus Clinical Research US Inc

    Birmingham, Alabama

  • Achieve Clinical Research, LLC

    Birmingham, Alabama

  • Optimal Research

    Huntsville, Alabama

  • Coastal Clinical Research, Inc

    Mobile, Alabama

  • Synexus Clinical Research US Inc

    Chandler, Arizona

  • Hope Research Institute

    Peoria, Arizona

  • Central Phoenix Medical Clinic

    Phoenix, Arizona

  • Medpharmics, LLC

    Phoenix, Arizona

  • Clinical Research Consortium Arizona

    Tempe, Arizona

  • Synexus Clinical Research US Inc

    Tucson, Arizona

  • Baptist Health Center For Clinical Research

    Little Rock, Arkansas

  • Rancho Paseo Medical Group

    Banning, California

  • Hope clinical Research LLC

    Canoga Park, California

  • Synexus Clinical Research US Inc

    Cerritos, California

  • eStudySite

    Chula Vista, California

  • Velocity Clinical Research, San Diego

    La Mesa, California

  • Paradigm Clinical Research Centers, Inc.

    Redding, California

  • Optimal Research

    San Diego, California

  • Encompass Clinical Research

    Spring Valley, California

  • Synexus Clinical Research US Inc

    Vista, California

  • Synexus Clinical Research US Inc

    Aurora, Colorado

  • Tekton Research Inc.

    Fort Collins, Colorado

  • Tekton Research Inc.

    Longmont, Colorado

  • Paradigm Clinical Research Centers, Inc.

    Wheat Ridge, Colorado

  • JEM Research LLC

    Atlantis, Florida

  • Clinical Research of South Florida, an AMR Company

    Coral Gables, Florida

  • Prestige Clinical Research Center, Inc.

    Coral Gables, Florida

  • Avail Clinical Research, LLC

    DeLand, Florida

  • Velocity Clinical Research, Inc.

    Edgewater, Florida

  • AMR Fort Myers Clinical Physiology Associates, an AMR company

    Fort Myers, Florida

  • Velocity Clinical Research, Hallandale Beach

    Hallandale, Florida

  • Westside Center for Clinical Research

    Jacksonville, Florida

  • Jacksonville Center For Clinical Research

    Jacksonville, Florida

  • Altus Research, Inc

    Lake Worth, Florida

  • Accel Research Sites

    Lakeland, Florida

  • Compass Research LLC

    Leesburg, Florida

  • Optimal Research

    Melbourne, Florida

  • Suncoast Research Group

    Miami, Florida

  • New Horizon Research Center

    Miami, Florida

Showing 40 of 272 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.